TORONTO, Dec. 10 /CNW/ - Biosign Technologies (TSXV: BIO), a novel health monitoring technology company, and We Care Health Services LP, a national Canadian homecare company, announced today the release of the 2010 Re-ACT© report.
The Remote Access to Care Technology, (Re-ACT©) program is an Aging at Home initiative that is funded by the North Simcoe Muskoka Local Health Integration Network (NSM LHIN) and supported by a partnership with NSM Community Care Access Centre (CCAC), We Care Home Health Services, and Biosign utilizing the Healthanywhere™ solution.
A key focus of the NSM LHIN is to implement strategies that help alleviate Emergency Room (ER) visits, prevent hospitalizations and prevent Alternate Level of Care beds (ALC). Re-ACT has proven to meet these expectations and more. The highlights are:
- 96% of clients are able to be maintained in their homes
- 92% clients are better informed about managing their chronic health conditions, are
able to self-identify and problem-solve
- 92% of clients know what signs and symptoms to look for and when to make an
appointment with their doctor
- 68% of clients believe that their home is safer than before being on the program
- 80% of clients feel that they will be able to stay in their home longer, than before Re-
Using Healthanywhere technology, Re-ACT© connects seniors living with chronic disease(s) to a Registered Nurse who monitors their vital signs remotely and encourages medication compliance, while providing assessment of vital signs (blood pressure, pulse, blood glucose, weight and blood oxygen), information about managing their chronic condition and adjustments to their care plan. This service is operated from We Care's Monitoring Centre in Barrie, Ontario during regular business hours. The nurse to client ratio of the Re-ACT© Program is 1:250. A goal of the Re- ACT© program is to help individuals develop skills for healthy living and managing their chronic condition. The program emphasizes the individual and family's role in their health care and encourages them to be an integral member of their health care team. It also engages them in decision making, goal setting, care planning and provides access to education programs and health information.
We Care successfully showcased Re-ACT at The Canadian Homecare Association conference, Banff 2009, Ontario Gerontology Association conference, Toronto 2009, Community Health Nurses' conference, Calgary 2009 and eHealth Summit, Gravenhurst, 2010.
About Biosign Technologies Inc.
Biosign Technologies Inc. (TSX-V: BIO) provides biomedical systems. Key applications include intelligent systems for noninvasive monitoring of common health risks associated with blood pressure, glucose, and medication. The core technology combines measurement, analysis, and rapid knowledge formation to support health monitoring across global markets. The UFIT® medical device technology powers quality data collection and analytics for clinical diagnostics, self-care, wellness, disease state evaluation & management, and remote patient monitoring. For more information on Biosign, please visit http://www.biosign.com
About We Care Health Services LP
We Care Health Services www.wecare.ca a leading national provider of in-home care and support services with over 50 locations across Canada, provides professional and compassionate care that allows seniors and others to live independently in the comfort of their own homes. We Care employs 3,000 homecare staff and provides care in over 800 communities across Canada.
This release contains forward-looking statements. Forward-looking statements, without limitation, may contain the words believes, expects, anticipates, estimates, intends, plans, or similar expressions. Forward-looking statements are not guarantees of future performance. They involve risks, uncertainties and assumptions and Biosign's actual results could differ materially from those anticipated. Forward looking statements are based on the opinions and estimates of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that could cause actual events or results to differ materially from those projected in the forward-looking statements. In the context of any forwardlooking information please refer to risk factors detailed in, as well as other information contained in, Biosign's filings with Canadian securities regulators (www.sedar.com).
Neither TSX Venture Exchange nor its Regulation Services Provider (as that term is defined in policies of the TSX Venture Exchange) accepts responsibility for the adequacy or accuracy of this release.
For further information: For further information:
Contact Information Biosign:
Radu Leca, President & CEO
Biosign Technologies Inc.
Phone: (416) 218-9800 ext. 234
Email: [email protected]
Contact Information WeCare:
For more information, contact:
We Care Health Services LP
Office: 647.259.1175 Cell: 416.993.6546
Email: [email protected]